Rankings
▼
Calendar
ORKA FY 2019 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ORKA
Oruka Therapeutics, Inc.
$1B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$89,000
Operating Income
-$6M
Net Income
-$5M
EPS (Diluted)
$-49.79
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$9M
Total Liabilities
$926,000
Stockholders' Equity
$8M
Cash & Equivalents
$8M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$89,000
-$22,000
-304.5%
Operating Income
-$6M
-$8M
+28.4%
Net Income
-$5M
-$8M
+30.9%
← Q4 2018
All Quarters
Q1 2019 →